Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renshu Chang Le granules in IBS-D (liver qi stagnation and spleen deficiency) phase II trial
CTR20180880Phase 2Active
- Sponsor
- Hong Kong Baptist University
- Start
- Jun 2018
- Countries
- 1
01
Overview
A Phase 2 trial of Renzhu Changle Granule in Diarrhea-predominant irritable bowel syndrome (IBS-D), sponsored by Hong Kong Baptist University. Started Jun 2018; status: active.
02
Drugs
Renzhu Changle Granule
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on CTR20180880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180880.